LUNG - Pulmonx Corp

5.19
-0.010   -0.193%

Share volume: 257,626
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%
$5.20
-0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
24%
Profitability 8%
Dept financing 18%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.39%
1 Month
-22.88%
3 Months
-10.98%
6 Months
-23.34%
1 Year
-30.80%
2 Year
-57.87%
Key data
Stock price
$5.19
P/E Ratio 
0.00
DAY RANGE
$5.02 - $5.41
EPS 
-$1.44
52 WEEK RANGE
$4.15 - $10.01
52 WEEK CHANGE
-$31.80
MARKET CAP 
268.123 M
YIELD 
N/A
SHARES OUTSTANDING 
39.153 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.40
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$284,594
AVERAGE 30 VOLUME 
$369,439
Company detail
CEO: Glendon E. French
Region: US
Website: pulmonx.com
Employees: 250
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Pulmonx Corporation provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service. It serves emphysema patients in the United States, Europe, the Middle East, Africa, Asia-Pacific and internationally.

Recent news
loading